HRT Financial’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-28,286
Closed -$87K 4067
2021
Q3
$87K Buy
+28,286
New +$87K ﹤0.01% 2668